Aldeyra Therapeutics, Inc.·4

Jun 12, 4:36 PM ET

Walker Neal 4

4 · Aldeyra Therapeutics, Inc. · Filed Jun 12, 2025

Insider Transaction Report

Form 4
Period: 2025-06-10
Walker Neal
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-06-10+62,72862,728 total
    Exercise: $2.69Exp: 2035-06-09Common Stock (62,728 underlying)
  • Award

    Stock Option (Right to Buy)

    2025-06-10+2,4132,413 total
    Exercise: $2.69Exp: 2035-06-09Common Stock (2,413 underlying)
Footnotes (2)
  • [F1]Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date.
  • [F2]Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Compensation Committee of the Board of Directors of the Issuer through the applicable vesting date.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4